Marken Announces Appointment of Chief Financial Officer Steve Menzies joins as new CFO and Board Director
LONDON, May 1, 2014 /PRNewswire/ -- Marken announced today the appointment of Steve J. Menzies as Chief Financial Officer and Board Director, Marken Group, effective May 1, 2014. He succeeds Alan Gullan, Marken's interim CFO, who stepped down from the same post on April 30.
Steve has 26 years of senior operational and board level finance experience, most recently as interim CFO for IMI plc's TA Hydronics business in Sweden. IMI is a £2bn turnover engineering company headquartered in Birmingham, UK. Prior to his role at IMI, he was Chief Financial Officer & Senior Vice President, Operational Excellence for First Data Corporation's $2bn International reporting segment, with responsibility for EMEA, APAC and Latin America & Canada. Earlier roles included Chief Financial Officer and Chief Operating Officer for Rockwell Automation's EMEA Region, VP Finance & Operations, EMEA at StorageTek, EVP Finance at Siebe plc, and Divisional Finance Director roles with GEC.
"I am delighted to welcome Steve to Marken," said Wes Wheeler, Marken's Chief Executive Officer, "Steve brings to us a wealth of international finance experience and leadership. He has an outstanding track record leading transformational change, delivering profitable double-digit growth, managing process improvements, and streamlining financial management in multinational public and private equity-owned companies. We look forward to leveraging all of Steve's formidable skills over the coming years."
"I am excited by the opportunity to work with Wes, the Board and the management team, and contribute to significant growth and shareholder value creation, said Steve. "I am committed to providing additional strength to the team as they continue to pursue their strategy and vision, and also contribute my experience to their ongoing operational excellence program."
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.